CompletedNot applicableNCT02342951

Evaluation of the Lung Clearance Index

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Muriel Le Bourgeois, MD
Service de pneumologie pédiatrique, Hôpital Necker-Enfants Malades Assistance Publique Hôpitaux de Paris 75015 Paris, France
Intervention
Lung clearance index determination(other)
Enrollment
53 enrolled
Eligibility
3-6 years · All sexes
Timeline
2014 – 2019

Study locations (1)

Collaborators

Vaincre la Mucoviscidose

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02342951 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis →

← Back to all trials